Fecal Calprotectin Turbo and Fecal Pancreatic Elastase Turbo Assays Are Available on VITROS Systems
QuidelOrtho and BÜHLMANN Laboratories have partnered to launch the fCAL turbo and fPELA turbo fecal biomarker assays on VITROS Systems.
QuidelOrtho and BÜHLMANN Laboratories have partnered to launch the fCAL turbo and fPELA turbo fecal biomarker assays on VITROS Systems.
Inconsistent use of CFCs—especially around replacement claims—is causing costly inefficiencies in healthcare billing.
A new microneedle-based wearable wristband enables real-time, painless monitoring of glucose, alcohol, lactate, and cardiovascular signals.
SPT Labtech and Semarion have partnered to integrate their respective technologies to streamline and scale adherent cell assay development.
Personalis has expanded and extended its partnership with Tempus AI to include colorectal cancer in their NeXT Personal MRD test.